Financials

  • Market Capitalization 15.3 M
  • Employee 18
  • Founded 2017
  • CEO N/A
  • Website vyometx.com
  • Headquarter Delaware, United States
  • FIGI BBG0036S6JY0
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
0
Rapporto prezzo/fatturato
27.95

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4697
PTN
Palatin Technologies, Inc. Common Stock
8.77 USD-7.88%-20.20%-29.90%+20.97%15.60 M USD
4703
AKTX
Akari Therapeutics Plc - American Depositary Shares
13.42 USD+0.15%-9.39%+4.35%+1120.00%15.36 M USD
4715
LEXX
Lexaria Bioscience Corp. - Common Stock
0.59 USD0.00%+7.27%-1.67%-27.16%14.62 M USD
4716
CTXR
Citius Pharmaceuticals, Inc. - Common Stock
0.53 USD-1.85%-11.67%-3.64%-68.07%14.55 M USD